Author:
Krzyzanski Wojciech,Smits Anne,Van Den Anker John,Allegaert Karel
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Food and Drug Administration. General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry. 2019. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-clinical-pharmacology-considerations-neonatal-studies-drugs-and-biological-products-guidance Accessed December 2020.
2. Ward RM, Benjamin D, Barrett JS, Allegaert K, Portman R, Davis JM, et al. Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates. Pediatr Res. 2017;81:692–711. https://doi.org/10.1038/pr.2016.221.
3. Guignard JP, Drukker A. Why do newborn infants have a high plasma creatinine? Pediatrics. 1999;103:e49.
4. Gubhaju L, Sutherland MR, Horne RS, Medhurst A, Kent AL, Ramsden A, et al. Assessment of renal functional maturation and injury in preterm neonates during the first month of life. Am J Physiol Renal Physiol. 2014;307:F149–58. https://doi.org/10.1152/ajprenal.00439.2013.
5. Grimsley C, Thomson AH. Pharmacokinetics and dose requirements of vancomycin in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;81:F221–7.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献